The Wall Street Journal indicates many businesses want liability protection against attacks in exchange for following the guidelines, which would require approvalform Congress in order to happen.
HeartWare said that the FDA was requiring the company to perform a post-approval study in the form of a registry consisting of 600 HeartWare patients and an additional 600 control patients.